Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Roden

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumorsChao-Yi Wu, Li-Hua Yang, Huang-Yu Yang, et al.
JCO Global Oncology|February 13, 2025
Optimizing Recruitment and Retention in Cancer Clinical Trials in Low-Resource Settings: Barriers and Facilitators From Nigerian Provider's PerspectivesBabayemi O Olakunde, Ngozi Idemili-Aronu, Tara M Friebel-Klingner, et al.
JCO Global Oncology|October 8, 2025
Barriers and Facilitators to Cancer Clinical Trial Participation: Perspectives of Patients in the ICON-3 Practice-Based Research Network, NigeriaNgozi Idemili-Aronu, Babayemi O Olakunde, Tara M Friebel-Klingner, et al.
ACS Omega|October 6, 2018
Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian CancerRavi K Anchoori, Rosie Jiang, Shiwen Peng, et al.
Vaccine|May 1, 2014
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypesKirill Kalnin, Timothy Tibbitts, Yanhua Yan, et al.
Journal of Virology|March 29, 2013
Phylogenetic considerations in designing a broadly protective multimeric L2 vaccineSubhashini Jagu, Kihyuck Kwak, John T Schiller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγRuey-Shyang Soong, Liwen Song, Janson Trieu, et al.
Cancer Cell|December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancerRavi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2015
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesJoshua W Wang, Subhashini Jagu, Wai-Hong Wu, et al.
Journal of Biomedical Optics|January 12, 2010
Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laserKong-Thon Tsen, Shaw-Wei D Tsen, Q Fu, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumorsChao-Yi Wu, Li-Hua Yang, Huang-Yu Yang, et al.
JCO Global Oncology|February 13, 2025
Optimizing Recruitment and Retention in Cancer Clinical Trials in Low-Resource Settings: Barriers and Facilitators From Nigerian Provider's PerspectivesBabayemi O Olakunde, Ngozi Idemili-Aronu, Tara M Friebel-Klingner, et al.
JCO Global Oncology|October 8, 2025
Barriers and Facilitators to Cancer Clinical Trial Participation: Perspectives of Patients in the ICON-3 Practice-Based Research Network, NigeriaNgozi Idemili-Aronu, Babayemi O Olakunde, Tara M Friebel-Klingner, et al.
ACS Omega|October 6, 2018
Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian CancerRavi K Anchoori, Rosie Jiang, Shiwen Peng, et al.
Vaccine|May 1, 2014
Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypesKirill Kalnin, Timothy Tibbitts, Yanhua Yan, et al.
Journal of Virology|March 29, 2013
Phylogenetic considerations in designing a broadly protective multimeric L2 vaccineSubhashini Jagu, Kihyuck Kwak, John T Schiller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2014
Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγRuey-Shyang Soong, Liwen Song, Janson Trieu, et al.
Cancer Cell|December 17, 2013
A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancerRavi K Anchoori, Balasubramanyam Karanam, Shiwen Peng, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2015
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesJoshua W Wang, Subhashini Jagu, Wai-Hong Wu, et al.
Journal of Biomedical Optics|January 12, 2010
Photonic approach to the selective inactivation of viruses with a near-infrared subpicosecond fiber laserKong-Thon Tsen, Shaw-Wei D Tsen, Q Fu, et al.
Pageof 18